The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
theracos | 222 |
theracos sub | 67 |
ge xu | 10 |
terakos | 2 |
theracos inc. (us) | 1 |
calyx therapeutics | 1 |
therakos | 1 |
theracos | 39 |
calyx therapeutics | 1 |
ge xu | 1 |
terakos | 1 |
theracos sub | 25 |
theracos | 5 |
ge xu | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
processes for the preparation of sglt2 inhibitors | 57 | 2008 |
treating obesity with muscarinic receptor m1 antagonists | 46 | 2006 |
benzylbenzene derivatives and methods of use | 44 | 2007 |
crystalline form of benzylbenzene sglt2 inhibitor | 37 | 2010 |
process for preparation of benzylbenzene sodium-dependent glucose cotransporter 2 (sglt2… 🛈 | 26 | 2012 |
deuterated benzylbenzene derivatives and methods of use | 25 | 2008 |
benzylphenyl cyclohexane derivatives and methods of use | 24 | 2007 |
preparation of hydroxy-benzylbenzene derivatives | 21 | 2013 |
benzylic glycoside derivatives and methods of use | 19 | 2007 |
novel heterocyclic analogs of diphenylethylene compounds | 7 | 2000 |